Skip to main
GTBP
GTBP logo

GTBP P/E Ratio

P/E Ratio as of Jun 13, 2025: -0.50

Average-0.4719
Median-0.4700
Minimum-0.5600
Maximum-0.3800
-0.50
Past Month-0.12 (31.58%)
The P/E ratio for GTBP is -0.50 as of Jun 13, 2025. This represents a increase of 42.86% compared to its 12-month average P/E ratio of -0.35. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

GT Biopharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

GT Biopharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing GT Biopharma Inc to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GTBP P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$2.71-0.47
May 1, 2025$2.45-0.35
Apr 1, 2025$2.37-0.34
Mar 3, 2025$2.33-0.33
Feb 3, 2025$2.25-0.30
Jan 2, 2025$2.94-0.39

GTBP End of Year P/E Ratio

DateP/E ratioChange
2025-0.50+21.95%
2024-0.41-53.93%
2023-0.89+4.71%
2022-0.85-24.78%
2021-1.13-5.83%
2020-1.20

FAQs About GT Biopharma Inc (GTBP) P/E ratio

The latest P/E ratio of GTBP is -0.50, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

GT Biopharma Inc’s last 12-month average P/E ratio is -0.35, compared to its current P/E ratio of -0.50. This reflects a increase of 42.86%.

GT Biopharma Inc’s current P/E ratio of -0.50 is higher than its last 12-month average P/E of -0.35. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

GT Biopharma Inc’s average P/E ratio over the last 3 years is -0.92. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

GT Biopharma Inc’s average P/E ratio over the last 5 years is -1.09. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

GT Biopharma Inc (GTBP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.